6 min read

Menopause and Your Heart: The Cardiovascular Risk Every Woman Should Know About

When most women think about menopause, they think about hot flushes, mood changes, and perhaps bone health. Very few think about their heart. Yet cardiovascular disease is the leading cause of death in women over 65 in the United Kingdom, and the risk begins to climb significantly after menopause. In my practice, I believe this is one of the most underappreciated aspects of the menopausal transition, and one where timely intervention can make a genuine difference.

The protective role of oestrogen

Before menopause, women enjoy a relative cardiovascular advantage compared to men of the same age. This protection is largely attributed to oestrogen, which plays several important roles in maintaining heart and blood vessel health:

This hormonal shield does not make women immune to heart disease before menopause, but it does contribute to a statistically lower risk during the reproductive years.

What changes after menopause

As oestrogen levels decline during the menopausal transition, these protective mechanisms gradually diminish. The result is a cascade of metabolic and vascular changes that increase cardiovascular risk. In the years following menopause, many women experience a shift in their cholesterol profile, with rising LDL and triglycerides and declining HDL. Blood pressure may begin to creep upward, even in women who have never had hypertension before. There is often an increase in central body fat — the fat that accumulates around the waist and abdomen — which is metabolically more active and associated with higher cardiovascular risk than fat stored elsewhere.

Additionally, blood vessel walls may become stiffer and less responsive, and markers of systemic inflammation tend to increase. These changes do not happen overnight; they unfold gradually over the menopausal transition and the years that follow, which is precisely why many women and even some clinicians do not make the connection between menopause and heart risk until it is too late.

Cholesterol, blood pressure, and metabolic changes

I encourage all my patients going through the menopausal transition to have a thorough cardiovascular health check. This should include:

Understanding your personal risk profile empowers you to take meaningful action before problems develop.

Hormone replacement therapy and the timing hypothesis

The relationship between hormone replacement therapy (HRT) and cardiovascular health has been the subject of considerable debate. The initial alarm raised by the Women's Health Initiative (WHI) study in 2002 led to a dramatic decline in HRT prescribing and left many women and doctors wary of hormonal treatment. However, subsequent reanalysis of the data, along with newer studies, has painted a more nuanced picture.

The current evidence supports what is known as the "timing hypothesis" — the idea that HRT may offer cardiovascular benefit when started within ten years of menopause onset or before the age of 60, but that beginning HRT many years after menopause in older women with established cardiovascular disease may not confer the same benefit and could carry increased risk. For women in the early menopausal window who are experiencing symptoms, HRT may help preserve vascular function, maintain favourable cholesterol levels, and support metabolic health.

It is important to emphasise that HRT decisions should be individualised. The type of HRT, the route of administration (transdermal versus oral), and the patient's personal and family history all matter. I discuss these considerations carefully with each patient, weighing the potential cardiovascular benefits alongside the management of menopausal symptoms and bone health.

Lifestyle factors that protect your heart

Regardless of whether you choose to take HRT, lifestyle modifications are the foundation of cardiovascular health during and after menopause. The evidence is clear that the following measures make a meaningful difference:

Screening recommendations and when to seek help

I recommend that all women have a baseline cardiovascular assessment around the time of the menopausal transition, typically between the ages of 45 and 55. This should be repeated regularly, particularly if risk factors are identified. If you have a family history of early heart disease, if you experienced pregnancy complications such as pre-eclampsia or gestational diabetes, or if you have polycystic ovary syndrome, you may be at higher risk and should discuss early screening with your doctor.

You should seek prompt medical attention if you experience any of the following:

It is worth noting that heart disease symptoms in women can be more subtle than the classic presentation seen in men. Women are more likely to experience fatigue, nausea, jaw pain, or back discomfort rather than crushing chest pain. Being aware of these differences can be life-saving.

Menopause is a pivotal moment for cardiovascular health. The loss of oestrogen's protective effects, combined with metabolic shifts, means that proactive screening and lifestyle changes during this transition can significantly reduce your long-term risk of heart disease.

Concerned about your cardiovascular health during menopause? I offer comprehensive menopause assessments that include cardiovascular risk evaluation, personalised lifestyle guidance, and a discussion of whether HRT may be appropriate for you.

Book a Consultation
← Back to All Articles